Globally health sectors have been under immense pressure as they are at the forefront of fighting against the spread and treatment of Covid-19. In South Africa the Innovative Pharmaceutical Association of South Africa (IPASA) is committed to ensuring that the supply of medicines for chronic diseases continues during the lock-down and that its 26 research-based pharmaceutical companies continue to aid in the fight against Covid-19. Joining CNBC Africa for more is Dr, Konji Sebati, CEO of the Innovative Pharmaceutical Association of South Africa.
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.